1. Home
  2. MIST vs ATLO Comparison

MIST vs ATLO Comparison

Compare MIST & ATLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • ATLO
  • Stock Information
  • Founded
  • MIST 2003
  • ATLO 1903
  • Country
  • MIST Canada
  • ATLO United States
  • Employees
  • MIST N/A
  • ATLO N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • ATLO Major Banks
  • Sector
  • MIST Health Care
  • ATLO Finance
  • Exchange
  • MIST Nasdaq
  • ATLO Nasdaq
  • Market Cap
  • MIST 163.2M
  • ATLO 186.3M
  • IPO Year
  • MIST N/A
  • ATLO N/A
  • Fundamental
  • Price
  • MIST $2.61
  • ATLO $21.75
  • Analyst Decision
  • MIST Strong Buy
  • ATLO
  • Analyst Count
  • MIST 3
  • ATLO 0
  • Target Price
  • MIST $6.33
  • ATLO N/A
  • AVG Volume (30 Days)
  • MIST 2.8M
  • ATLO 16.1K
  • Earning Date
  • MIST 11-12-2025
  • ATLO 10-17-2025
  • Dividend Yield
  • MIST N/A
  • ATLO 3.66%
  • EPS Growth
  • MIST N/A
  • ATLO 82.57
  • EPS
  • MIST N/A
  • ATLO 1.80
  • Revenue
  • MIST N/A
  • ATLO $60,568,000.00
  • Revenue This Year
  • MIST N/A
  • ATLO N/A
  • Revenue Next Year
  • MIST N/A
  • ATLO N/A
  • P/E Ratio
  • MIST N/A
  • ATLO $12.17
  • Revenue Growth
  • MIST N/A
  • ATLO 18.60
  • 52 Week Low
  • MIST $0.63
  • ATLO $15.75
  • 52 Week High
  • MIST $2.75
  • ATLO $21.90
  • Technical
  • Relative Strength Index (RSI)
  • MIST 74.94
  • ATLO 66.59
  • Support Level
  • MIST $2.31
  • ATLO $20.80
  • Resistance Level
  • MIST $2.49
  • ATLO $21.47
  • Average True Range (ATR)
  • MIST 0.19
  • ATLO 0.35
  • MACD
  • MIST 0.06
  • ATLO 0.04
  • Stochastic Oscillator
  • MIST 95.50
  • ATLO 96.04

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About ATLO Ames National Corporation

Ames National Corporation is a United States-based bank holding company. It provides short-term and medium-term commercial, multi-family, and agricultural real estate loans, residential real estate loans, agricultural and business operating loans and lines of credit, equipment loans, vehicle loans, personal loans and lines of credit, home improvement loans and origination of mortgage loans for sale into the secondary market. The Banks also offer a variety of checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit and automated/video teller machine access. The banking segment generates revenues through personal, business, agricultural and commercial lending, and Others.

Share on Social Networks: